• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • MIMLIVEROnChip
      • NEUROCELL3D
      • ONCO3D
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
    • How to buy BIOMIMESYS®?
  • Assay Services
    • Dermocosmetology
      • Anti-Aging
      • Slimming
      • Anti-Oxidant
      • Anti-Redness
      • Wound Healing
      • Skin Pigmentation
      • Anti-Pollution
      • Skin Microbiota
      • Custom Your Assay In Dermocosmetics
    • Pharmacology
      • Custom Your 3D Phenotypic Assay In Oncology
      • 3D Parkinson’s Disease
      • Migration
      • Cell cycle arrest
      • 3D Screening against Liver Cancer
      • Anti-colon Cancer Drug Assessment In 3D
    • Toxicology
      • 3D Neurotoxicity Assessment
  • Ressources
    • Publications – Scientific articles
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificates of Analysis
    • TDS&MSDS
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us?
    • How to buy BIOMIMESYS®?
    • Subscribe to our Newsletter
    • Join Us

need

Biomimesys

A comparison between tumor-derived hydrogels and BIOMIMESYS®

There are several products today for 3D cell culture and many could be considered as “hydrogels”. In this short article, we explain differences between BIOMIMESYS® and hydrogels to help you to choose the right product for your very specific needs. In 3D cell cultures, many hydrogels could be used like Read more…

By Grégory MAUBON, 1 yearAugust 4, 2022 ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • HCS Pharma at 8th Bioproduction congress in Lyon on october 4-6 2023
  • Feedback of Rania’s internship about the development of primary human hepatocyte model in biochip microfludic system
  • Join us in Paris at Cosmetic 360, October 18 and 19
  • Nathalie Maubon in China on the 27th of September for the life science summit
  • HCS Pharma @ELRIG congress in Basel “Advancements in cell & gene therapy: new therapeutic horizons” on Friday, 15th september 2023
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain brain cancer cell congress cosmetology dermocosmetology drug Drug discovery ECM ELRIG event extracellular matrix genotoxicity HCS hcs pharma High content screening hydroscaffold imaging innovation in vitro in vitro models liver meeting Microbiota microscopy Molecular Devices NEUROCELL3D neurotoxicity ONCO3D oncology organoids Parkinson phenotypic screening picture poster R&D screening skin toxicology webinar
  • Company
  • BIOMIMESYS®
  • Assay Services
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress
 

Loading Comments...